Rhenman & Partners Asset Management AB 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
RP
Rhenman & Partners Asset Management AB
Institutional Filer 24.25%$810.5M86

Current Portfolio Holdings

Showing all 86 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1BSXBoston Scientific CorporationHealthcare625K$39.2M4.84%
2REGNRegeneron Pharmaceuticals, Inc.Healthcare48K$37.2M4.59%
3LLYEli Lilly and CompanyHealthcare34K$31.0M3.83%
4INSMInsmed IncorporatedHealthcare160K$26.1M3.22%
5CVSCVS Health CorporationHealthcare337K$24.2M2.98%
6GILDGilead Sciences, Inc.Healthcare168K$23.4M2.88%
7TMOThermo Fisher Scientific Inc.Healthcare41K$20.3M2.51%
8BIIBBiogen Inc.Healthcare109K$20.0M2.47%
9VRTXVertex Pharmaceuticals IncorporatedHealthcare43K$19.4M2.40%
10ALHCAlignment Healthcare, Inc.Healthcare1.1M$18.6M2.29%
11ISRGIntuitive Surgical, Inc.Healthcare37K$17.0M2.10%
12CORCencora, Inc.Healthcare52K$16.5M2.03%
13SYKStryker CorporationHealthcare48K$15.7M1.94%
14ABBVAbbVie Inc.Healthcare72K$15.6M1.92%
15VEEVVeeva Systems Inc.Healthcare85K$15.0M1.85%
Showing 1 to 15 of 86 holdings
Rhenman & Partners Asset Management AB 13F Portfolio Holdings & Trades (Q1 2026) | VCP Scanner